{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T11:30:20Z","timestamp":1789731020131,"version":"4.0.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2014,8,5]],"date-time":"2014-08-05T00:00:00Z","timestamp":1407196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/3.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1038\/bjc.2014.421","type":"journal-article","created":{"date-parts":[[2014,8,5]],"date-time":"2014-08-05T20:01:47Z","timestamp":1407268907000},"page":"1168-1179","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Inhibition of Hedgehog signalling by NVP-LDE225 (Erismodegib) interferes with growth and invasion of human renal cell carcinoma cells"],"prefix":"10.1038","volume":"111","author":[{"given":"C","family":"D\u2019Amato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Marciano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"D\u2019Amato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Formisano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Nappi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Raimondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Di Mauro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Servetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Fulciniti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Cipolletta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Bianco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Ciardiello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B M","family":"Veneziani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"De Placido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Bianco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,8,5]]},"reference":[{"key":"BFbjc2014421_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1093\/annonc\/mdi002","volume":"16","author":"RJ Amato","year":"2005","unstructured":"Amato RJ (2005) Renal cell carcinoma: review of novel single-agent therapeutics and combination regimens. Ann Oncol 16: 7\u201315.","journal-title":"Ann Oncol"},{"issue":"1","key":"BFbjc2014421_CR2","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.critrevonc.2013.02.006","volume":"88","author":"P Barth\u00e9l\u00e9my","year":"2013","unstructured":"Barth\u00e9l\u00e9my P, Hoch B, Chevreau C, Joly F, Laguerre B, Lokiec F, Duclos B (2013) mTOR inhibitors in advanced renal cell carcinomas: From biology to clinical practice. Crit Rev Oncol Hematol 88 (1): 42\u201356.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"8","key":"BFbjc2014421_CR3","doi-asserted-by":"publisher","first-page":"547","DOI":"10.4111\/kju.2013.54.8.547","volume":"54","author":"HM Behnsawy","year":"2013","unstructured":"Behnsawy HM, Shigemura K, Meligy FY, Yamamichi F, Yamashita M, Haung WC, Li X, Miyake H, Tanaka K, Kawabata M, Shirakawa T, Fujisawa M (2013) Possible role of sonic hedgehog and epithelial-mesenchymal transition in renal cell cancer progression. Korean J Urol 54 (8): 547\u2013554.","journal-title":"Korean J Urol"},{"issue":"6","key":"BFbjc2014421_CR4","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.ctrv.2014.02.003","volume":"40","author":"J Brechbiel","year":"2014","unstructured":"Brechbiel J, Miller-Moslin K, Adjei AA (2014) Crosstalk between hedgehog and other signaling pathways as a basis for combination therapies in cancer. Cancer Treat Rev 40 (6): 750\u2013759, S0305-7372(14)00023-1.","journal-title":"Cancer Treat Rev"},{"issue":"1","key":"BFbjc2014421_CR5","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/onc.2011.219","volume":"31","author":"X Cao","year":"2012","unstructured":"Cao X, Geradts J, Dewhirst MW, Lo HW (2012) Upregulation of VEGF-A and CD24 gene expression by the tGLI1 transcription factor contributes to the aggressive behavior of breast cancer cells. Oncogene 31 (1): 104\u2013115.","journal-title":"Oncogene"},{"issue":"21","key":"BFbjc2014421_CR6","doi-asserted-by":"publisher","first-page":"8667","DOI":"10.1158\/0008-5472.CAN-08-2614","volume":"68","author":"Y Cao","year":"2008","unstructured":"Cao Y, Wang L, Nandy D, Zhang Y, Basu A, Radisky D, Mukhopadhyay D (2008) Neuropilin-1 upholds dedifferentiation and propagation phenotypes of Renal Cell Carcinoma cells by activating Akt and Sonic Hedgehog axes. Cancer Res 68 (21): 8667\u20138672.","journal-title":"Cancer Res"},{"issue":"6024","key":"BFbjc2014421_CR7","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1126\/science.1203543","volume":"331","author":"CL Chaffer","year":"2011","unstructured":"Chaffer CL, Weinberg RA (2011) A perspective on cancer cell metastasis. Science 331 (6024): 1559\u20131564.","journal-title":"Science"},{"issue":"5","key":"BFbjc2014421_CR8","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1097\/PAP.0b013e3180ca8a1d","volume":"14","author":"NS Chari","year":"2007","unstructured":"Chari NS, McDonnell TJ (2007) The sonic hedgehog signaling network in development and neoplasia. Adv Anat Pathol. 14 (5): 344\u2013352.","journal-title":"Adv Anat Pathol."},{"issue":"1","key":"BFbjc2014421_CR9","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S0092-8674(03)00199-5","volume":"113","author":"F Charron","year":"2003","unstructured":"Charron F, Stein E, Jeong J, McMahon AP, Tessier-Lavigne M (2003) The morphogen sonic hedgehog is an axonal chemoattractant that collaborates with netrin-1 in midline axon guidance. Cell 113 (1): 11\u201323.","journal-title":"Cell"},{"key":"BFbjc2014421_CR10","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","volume":"22","author":"TC Chou","year":"1984","unstructured":"Chou TC, Talalay P (1984) Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul 22: 27\u201355.","journal-title":"Adv Enzyme Regul"},{"issue":"8","key":"BFbjc2014421_CR11","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1038\/bjc.2013.153","volume":"108","author":"V Damiano","year":"2013","unstructured":"Damiano V, Rosa R, Formisano L, Nappi L, Gelardi T, Marciano R, Cozzolino I, Troncone G, Agrawal S, Veneziani BM, De Placido S, Bianco R, Tortora G (2013) Toll-like receptor 9 agonist IMO cooperates with everolimus in renal cell carcinoma by interfering with tumour growth and angiogenesis. Br J Cancer 108 (8): 1616\u20131623.","journal-title":"Br J Cancer"},{"issue":"17","key":"BFbjc2014421_CR12","doi-asserted-by":"publisher","first-page":"11824","DOI":"10.1074\/jbc.M112.432302","volume":"288","author":"S Das","year":"2013","unstructured":"Das S, Samant RS, Shevde LA (2013) Nonclassical activation of Hedgehog signaling enhances multidrug resistance and makes cancer cells refractory to Smoothened-targeting Hedgehog inhibition. J Biol Chem 288 (17): 11824\u201311833.","journal-title":"J Biol Chem"},{"key":"BFbjc2014421_CR13","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/1476-4598-8-123","volume":"8","author":"V Dormoy","year":"2009","unstructured":"Dormoy V, Danilin S, Lindner V, Thomas L, Rothhut S, Coquard C, Helwig JJ, Jacqmin D, Lang H, Massfelder T (2009) The sonic hedgehog signaling pathway is reactivated in human renal cell carcinoma and plays orchestral role in tumor growth. Mol Cancer 8: 123.","journal-title":"Mol Cancer"},{"issue":"42","key":"BFbjc2014421_CR14","doi-asserted-by":"publisher","first-page":"43929","DOI":"10.1074\/jbc.M401418200","volume":"279","author":"M Errico","year":"2004","unstructured":"Errico M, Riccioni T, Iyer S, Pisano C, Acharya KR, Persico MG, De Falco S (2004) Identification of placenta growth factor determinants for binding and activation of Flt-1 receptor. J Biol Chem 279 (42): 43929\u201343939.","journal-title":"J Biol Chem"},{"issue":"12","key":"BFbjc2014421_CR15","first-page":"670","volume":"37","author":"C Fellner","year":"2012","unstructured":"Fellner C (2012) Vismodegib (Erivedge) for advanced basal cell carcinoma. P T 37 (12): 670\u2013682.","journal-title":"P T"},{"key":"BFbjc2014421_CR16","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1097\/SLA.0b013e318236bc0f","volume":"254","author":"V Fendrich","year":"2011","unstructured":"Fendrich V, Wiese D, Waldmann J, Lauth M, Heverhagen AE, Rehm J, Bartsch DK (2011) Hedgehog inhibition with the orally bioavailable Smo antagonist LDE225 represses tumor growth and prolongs survival in a transgenic mouse model of islet cell neoplasms. Ann Surg 254: 818\u2013823, discussion 823.","journal-title":"Ann Surg"},{"issue":"Suppl 2","key":"BFbjc2014421_CR17","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1634\/theoncologist.2011-S2-04","volume":"16","author":"DS Finley","year":"2011","unstructured":"Finley DS, Pantuck AJ, Belldegrun AS (2011) Tumor biology and prognostic factors in renal cell carcinoma. Oncologist 16 (Suppl 2): 4\u201313.","journal-title":"Oncologist"},{"issue":"19","key":"BFbjc2014421_CR18","doi-asserted-by":"publisher","first-page":"4883","DOI":"10.1158\/0008-5472.CAN-12-1223","volume":"72","author":"D Gao","year":"2012","unstructured":"Gao D, Vahdat LT, Wong S, Chang JC, Mittal V (2012) Microenvironmental regulation of epithelial-mesenchymal transitions in cancer. Cancer Res. 72 (19): 4883\u20134889.","journal-title":"Cancer Res."},{"issue":"11","key":"BFbjc2014421_CR19","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1038\/nm.3328","volume":"19","author":"M Gruber Filbin","year":"2013","unstructured":"Gruber Filbin M, Dabral SK, Pazyra-Murphy MF, Ramkissoon S, Kung AL, Pak E, Chung J, Theisen MA, Sun Y, Franchetti Y, Sun Y, Shulman DS, Redjal N, Tabak B, Beroukhim R, Wang Q, Zhao J, Dorsch M, Buonamici S, Ligon KL, Kelleher JF, Segal RA (2013) Coordinate activation of Shh and PI3K signaling in PTEN-deficient glioblastoma: new therapeutic opportunities. Nat Med 19 (11): 1518\u20131523.","journal-title":"Nat Med"},{"issue":"7","key":"BFbjc2014421_CR20","doi-asserted-by":"publisher","first-page":"3033","DOI":"10.3390\/ijms10073033","volume":"10","author":"ME Han","year":"2009","unstructured":"Han ME, Lee YS, Baek SY, Kim BS, Kim JB, Oh SO (2009) Hedgehog signaling regulates the survival of gastric cancer cells by regulating the expression of bcl-2. Int J Mol Sci 10 (7): 3033\u20133043.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"BFbjc2014421_CR21","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1158\/0008-5472.CAN-11-2681","volume":"72","author":"E Heller","year":"2012","unstructured":"Heller E, Hurchla MA, Xiang J, Su X, Chen S, Schneider J, Joeng KS, Vidal M, Goldberg L, Deng H, Hornick MC, Prior JL, Piwnica-Worms D, Long F, Cagan R, Weilbaecher KN (2012) Hedgehog signaling inhibition blocks growth of resistant tumors through effects on tumor microenvironment. Cancer Res 72 (4): 897\u2013907.","journal-title":"Cancer Res"},{"issue":"3","key":"BFbjc2014421_CR22","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1158\/0008-5472.CAN-09-3722","volume":"70","author":"D Huang","year":"2010","unstructured":"Huang D, Ding Y, Li Y, Luo WM, Zhang ZF, Snider J, Vandenbeldt K, Qian CN, Teh BT (2010a) Sunitinib acts primarily on tumor endothelium rather than tumor cells to inhibit the growth of renal cell carcinoma. Cancer Res 70 (3): 1053\u20131062.","journal-title":"Cancer Res"},{"issue":"3","key":"BFbjc2014421_CR23","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1158\/0008-5472.CAN-09-3965","volume":"70","author":"D Huang","year":"2010","unstructured":"Huang D, Ding Y, Zhou M, Rini BI, Petillo D, Qian CN, Kahnoski R, Futreal PA, Furge KA, Teh BT (2010b) Interleukin-8 mediates resistance to antiangiogenic agent sunitinib in renal cell carcinoma. Cancer Res 70 (3): 1063\u20131071.","journal-title":"Cancer Res"},{"issue":"6","key":"BFbjc2014421_CR24","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1038\/onc.2010.459","volume":"30","author":"S Inaguma","year":"2011","unstructured":"Inaguma S, Kasai K, Ikeda H (2011) GLI1 facilitates the migration and invasion of pancreatic cancer cells through MUC5AC-mediated attenuation of E-cadherin. Oncogene 30 (6): 714\u2013723.","journal-title":"Oncogene"},{"issue":"11","key":"BFbjc2014421_CR25","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1002\/cyto.a.22095","volume":"81","author":"F Leccia","year":"2012","unstructured":"Leccia F, Nardone A, Corvigno S, Vecchio LD, De Placido S, Salvatore F, Veneziani BM (2012) Cytometric and biochemical characterization of human breast cancer cells reveals heterogeneous myoepithelial phenotypes. Cytometry A 81 (11): 960\u2013972.","journal-title":"Cytometry A"},{"issue":"1","key":"BFbjc2014421_CR26","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1093\/toxsci\/kfn076","volume":"104","author":"RJ Lipinski","year":"2008","unstructured":"Lipinski RJ, Hutson PR, Hannam PW, Nydza RJ, Washington IM, Moore RW, Girdaukas GG, Peterson RE, Bushman W (2008) Dose- and route-dependent teratogenicity, toxicity, and pharmacokinetic profiles of the hedgehog signaling antagonist cyclopamine in the mouse. Toxicol Sci 104 (1): 189\u2013197.","journal-title":"Toxicol Sci"},{"issue":"7","key":"BFbjc2014421_CR27","doi-asserted-by":"publisher","first-page":"e40480","DOI":"10.1371\/journal.pone.0040480","volume":"7","author":"Z Liu","year":"2012","unstructured":"Liu Z, Zhang B, Liu K, Ding Z, Hu X (2012) Schisandrin B attenuates cancer invasion and metastasis via inhibiting epithelial-mesenchymal transition. PLoS One 7 (7): e40480.","journal-title":"PLoS One"},{"issue":"20","key":"BFbjc2014421_CR28","first-page":"5867","volume":"62","author":"ID Louro","year":"2002","unstructured":"Louro ID, Bailey EC, Li X, South LS, McKie-Bell PR, Yoder BK, Huang CC, Johnson MR, Hill AE, Johnson RL, Ruppert JM (2002) Comparative gene expression profile analysis of GLI and c-MYC in an epithelial model of malignant transformation. Cancer Res 62 (20): 5867\u20135873.","journal-title":"Cancer Res"},{"issue":"1","key":"BFbjc2014421_CR29","doi-asserted-by":"publisher","first-page":"e16068","DOI":"10.1371\/journal.pone.0016068","volume":"6","author":"MY Maitah","year":"2011","unstructured":"Maitah MY, Ali S, Ahmad A, Gadgeel S, Sarkar FH (2011) Up-regulation of sonic hedgehog contributes to TGF-\u03b21-induced epithelial to mesenchymal transition in NSCLC cells. PLoS One 6 (1): e16068.","journal-title":"PLoS One"},{"issue":"18","key":"BFbjc2014421_CR30","doi-asserted-by":"publisher","first-page":"4883","DOI":"10.1158\/1078-0432.CCR-11-2509","volume":"18","author":"R McMillan","year":"2012","unstructured":"McMillan R, Matsui W (2012) Molecular pathways: the hedgehog signaling pathway in cancer. Clin Cancer Res 18 (18): 4883\u20134888.","journal-title":"Clin Cancer Res"},{"issue":"5","key":"BFbjc2014421_CR31","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1002\/pmic.201200303","volume":"13","author":"F Monteleone","year":"2013","unstructured":"Monteleone F, Rosa R, Vitale M, D'Ambrosio C, Succoio M, Formisano L, Nappi L, Romano MF, Scaloni A, Tortora G, Bianco R, Zambrano N (2013) Increased anaerobic metabolism is a distinctive signature in a colorectal cancer cellular model of resistance to antiepidermal growth factor receptor antibody. Proteomics 13 (5): 866\u2013877.","journal-title":"Proteomics"},{"issue":"5","key":"BFbjc2014421_CR32","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1016\/j.juro.2007.07.030","volume":"178","author":"RJ Motzer","year":"2007","unstructured":"Motzer RJ, Michaelson MD, Rosenberg J, Bukowski RM, Curti BD, George DJ, Hudes GR, Redman BG, Margolin KA, Wilding G (2007) Sunitinib efficacy against advanced renal cell carcinoma. J Urol 178 (5): 1883\u20131887.","journal-title":"J Urol"},{"issue":"3","key":"BFbjc2014421_CR33","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1053\/j.gastro.2009.05.053","volume":"137","author":"MT Mueller","year":"2009","unstructured":"Mueller MT, Hermann PC, Witthauer J, Rubio-Viqueira B, Leicht SF, Huber S, Ellwart JW, Mustafa M, Bartenstein P, D'Haese JG, Schoenberg MH, Berger F, Jauch KW, Hidalgo M, Heeschen C (2009) Combined targeted treatment to eliminate tumorigenic cancer stem cells in human pancreatic cancer. Gastroenterology 137 (3): 1102\u20131113.","journal-title":"Gastroenterology"},{"issue":"4","key":"BFbjc2014421_CR34","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1007\/s00535-011-0507-6","volume":"47","author":"M Nakamura","year":"2012","unstructured":"Nakamura M, Tanaka H, Nagayoshi Y, Nakashima H, Tsutsumi K, Ohtsuka T, Takahata S, Tanaka M, Okada H (2012) Targeting the hedgehog pathway with interacting peptides to Patched-1. J Gastroenterol. 47 (4): 452\u2013460.","journal-title":"J Gastroenterol."},{"issue":"1","key":"BFbjc2014421_CR35","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s10616-010-9328-3","volume":"63","author":"A Nardone","year":"2011","unstructured":"Nardone A, Corvigno S, Brescia A, D'Andrea D, Limite G, Veneziani BM (2011) Long-term cultures of stem\/progenitor cells from lobular and ductal breast carcinomas under non-adherent conditions. Cytotechnology 63 (1): 67\u201380.","journal-title":"Cytotechnology"},{"issue":"10","key":"BFbjc2014421_CR36","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/S1470-2045(09)70240-2","volume":"10","author":"BI Rini","year":"2009","unstructured":"Rini BI, Atkins MB (2009) Resistance to targeted therapy in renal-cell carcinoma. Lancet Oncol 10 (10): 992\u20131000.","journal-title":"Lancet Oncol"},{"key":"BFbjc2014421_CR37","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1200\/JCO.2005.01.186","volume":"23","author":"BI Rini","year":"2005","unstructured":"Rini BI, Small EJ (2005) Biology and clinical development of vascular endothelial growth factor-targeted therapy in renal cell carcinoma. J Clin Oncol 23: 1028\u20131043.","journal-title":"J Clin Oncol"},{"issue":"1","key":"BFbjc2014421_CR38","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1158\/1078-0432.CCR-12-1050","volume":"19","author":"R Rosa","year":"2013","unstructured":"Rosa R, Marciano R, Malapelle U, Formisano L, Nappi L, D'Amato C, D'Amato V, Damiano V, Marf\u00e8 G, Del Vecchio S, Zannetti A, Greco A, De Stefano A, Carlomagno C, Veneziani BM, Troncone G, De Placido S, Bianco R (2013) Sphingosine kinase 1 overexpression contributes to cetuximab resistance in human colorectal cancer models. Clin Cancer Res 19 (1): 138\u2013147.","journal-title":"Clin Cancer Res"},{"issue":"7","key":"BFbjc2014421_CR39","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1023\/A:1020992411420","volume":"19","author":"T Schneider","year":"2002","unstructured":"Schneider T, Osl F, Friess T, Stockinger H, Scheuer WV (2002) Quantification of human Alu sequences by real-time PCR\u2013an improved method to measure therapeutic efficacy of anti-metastatic drugs in human xenotransplants. Clin Exp Metastasis 19 (7): 571\u2013582.","journal-title":"Clin Exp Metastasis"},{"issue":"23","key":"BFbjc2014421_CR40","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1056\/NEJMoa1113713","volume":"366","author":"A Sekulic","year":"2012","unstructured":"Sekulic A, Migden MR, Oro AE, Dirix L, Lewis KD, Hainsworth JD, Solomon JA, Yoo S, Arron ST, Friedlander PA, Marmur E, Rudin CM, Chang AL, Low JA, Mackey HM, Yauch RL, Graham RA, Reddy JC, Hauschild A (2012) Efficacy and safety of vismodegib in advanced basal-cell carcinoma. N Engl J Med 366 (23): 2171\u20132179.","journal-title":"N Engl J Med"},{"issue":"16","key":"BFbjc2014421_CR41","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1002\/pros.21388","volume":"71","author":"K Shigemura","year":"2011","unstructured":"Shigemura K, Huang WC, Li X, Zhau HE, Zhu G, Gotoh A, Fujisawa M, Xie J, Marshall FF, Chung LW (2011) Active sonic hedgehog signaling between androgen independent human prostate cancer cells and normal\/benign but not cancer-associated prostate stromal cells. Prostate 71 (16): 1711\u20131722.","journal-title":"Prostate"},{"issue":"7","key":"BFbjc2014421_CR42","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1158\/1535-7163.MCT-11-1058","volume":"11","author":"AD Steg","year":"2012","unstructured":"Steg AD, Katre AA, Bevis KS, Ziebarth A, Dobbin ZC, Shah MM, Alvarez RD, Landen CN (2012) Smoothened antagonists reverse taxane resistance in ovarian cancer. Mol Cancer Ther 11 (7): 1587\u20131597.","journal-title":"Mol Cancer Ther"},{"issue":"2","key":"BFbjc2014421_CR43","first-page":"181","volume":"1805","author":"Teglund and Toftg\u00e5rd","year":"2010","unstructured":"Teglund and Toftg\u00e5rd (2010) Hedgehog beyond medulloblastoma and basal cell carcinoma. Biochim Biophys Acta 1805 (2): 181\u2013208.","journal-title":"Biochim Biophys Acta"},{"issue":"17","key":"BFbjc2014421_CR44","doi-asserted-by":"publisher","first-page":"4371","DOI":"10.1242\/dev.01304","volume":"131","author":"SA Vokes","year":"2004","unstructured":"Vokes SA, Yatskievych TA, Heimark RL, McMahon J, McMahon AP, Antin PB, Krieg PA (2004) Hedgehog signaling is essential for endothelial tube formation during vasculogenesis. Development 131 (17): 4371\u20134380.","journal-title":"Development"},{"issue":"22","key":"BFbjc2014421_CR45","doi-asserted-by":"crossref","first-page":"5301","DOI":"10.1242\/dev.129.22.5301","volume":"129","author":"J Yu","year":"2002","unstructured":"Yu J, Carroll TJ, McMahon AP (2002) Sonic hedgehog regulates proliferation and differentiation of mesenchymal cells in the mouse metanephric kidney. Development 129 (22): 5301\u20135312.","journal-title":"Development"},{"issue":"1","key":"BFbjc2014421_CR46","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1756-9966-33-34","volume":"33","author":"D Yue","year":"2014","unstructured":"Yue D, Li H, Che J, Zhang Y, Tseng HH, Jin JQ, Luh TM, Giroux-Leprieur E, Mo M, Zheng Q, Shi H, Zhang H, Hao X, Wang C, Jablons DM, He B (2014) Hedgehog\/Gli promotes epithelial-mesenchymal transition in lung squamous cell carcinomas. J Exp Clin Cancer Res 33 (1): 34.","journal-title":"J Exp Clin Cancer Res"},{"issue":"4","key":"BFbjc2014421_CR47","doi-asserted-by":"publisher","first-page":"e19144","DOI":"10.1371\/journal.pone.0019144","volume":"6","author":"L Zhang","year":"2011","unstructured":"Zhang L, Bhasin M, Schor-Bardach R, Wang X, Collins MP, Panka D, Putheti P, Signoretti S, Alsop DC, Libermann T, Atkins MB, Mier JW, Goldberg SN, Bhatt RS (2011) Resistance of renal cell carcinoma to Sorafenib is mediated by potentially reversible gene expression. PLoS One 6 (4): e19144.","journal-title":"PLoS One"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/bjc2014421.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc2014421","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc2014421.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T13:25:06Z","timestamp":1684416306000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bjc2014421"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,5]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["BFbjc2014421"],"URL":"https:\/\/doi.org\/10.1038\/bjc.2014.421","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,5]]},"assertion":[{"value":"27 March 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2014","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2014","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2014","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}